Intimation of Trading Approval received from BSE Limited for 5,00,000 equity shares of Rs. 10/- each has been attached herewith.

07th October, 2026 The General Manager, Listing Department, BSE Limited Pheeroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001, Maharashtra India Symbol: DHARTI Scrip Code: 531171 Dear Sir/Madam, Subject: Intimation of Trading Approval received from BSE Limited for 5,00,000 Equity shares of Rs. 10/‐ each. We are pleased to inform that BSE Limited vide its notice 20261006-22 dated October 01, 2026 has granted approval for trading of 5,00,000 shares of Rs. 10/- each allotted to Successful Resolution Applicants (SRA) and its group of promoters and Secured Financial Creditor on preferential basis and to Existing Public Shareholders by way of Reduction of Share Capital on Proportionate basis as per approved Resolution Plan by Hon’ble NCLT, Ahmedabad Bench vide Order dated 18th November, 2025. Further, the shareholders are requested to take note that the shares of Company will be traded on BSE from Thursday, October 08, 2026. The details as required under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) (as amended) read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is enclosed herewith as Annexure-A. Copy of the trading approval from the Bombay Stock Exchange is enclosed herewith for your reference. You are requested to take note of the same. Yours Faithfully, For DHARTI PROTEINS LIMITED (Formerly Devika Proteins Limited) Twinkle Bipinchandra Gajjar Company Secretary and Compliance Officer ICSI Membership No. A77101 Annexure-A Relevant details under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) (as amended) read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. Sr. No Particulars Description Name of the regulatory or 1. BSE Limited licensing authority; Trading Approval for Trading of 5,00,000 Equity Shares of Rs. 10/- each allotted to Brief details of the Successful Resolution Applicants (SRA) and its 2. approval/license obtained/ group of Promoters and Secured Financial withdrawn/ surrendered; Creditor on Preferential basis and to Existing Public Shareholders by way of Reduction of Share Capital on a proportionate basis. Impact/relevance of such Upon receipt of Trading approval, the 5,00,000 3. approval/license to the listed Equity Shares of the Company would be entity; admitted to Trading on BSE. Withdrawal/cancellation or suspension of license/approval by the regulatory or licensing 4. authority, with reasons for such — action, estimated impact (monetary or otherwise) on the listed entity and penalty, if any; Period for which such 5. Not Applicable approval/license is/was valid; The actual impact (monetary or otherwise) along with corrective actions taken by the listed entity 6. — pursuant to the withdrawal, cancellation or suspension of the key license/ approval. NOTICE Notice No. 20261006-22 Notice Date 06 Oct 2026 Category Company related Segment Equity Department Listing Operations Subject Listing of Equity Shares of Dharti Proteins Limited Attachments Annexure-I All Market Participants are hereby informed that effective from Thursday i.e., October 8, 2026, the equity shares of the Company viz. Dharti Proteins Ltd (“the Company” or “Corporate Debtor”) shall be listed, admitted to dealings on the Exchange under XT Group. The securities shall be available for trading in XT group and shall continue to take place in Trade-to-Trade segment in accordance with Exchange Notice No. 20230210-55 dated February 10, 2023. Further, all Market Participants are requested to note that, the above Company will be a part of special pre-open session for IPO and Other category of scrips as per SEBI Circular No. CIR/MRD/DP/01/2012 and CIR/MRD/DP/02/2012 dated January 20, 2012, respectively. Name of the Company : Dharti Proteins Ltd Registered Office : A-1115, Titanium Business Park, Near Makarba Underpass, Makarba, Ahmedabad, Gujarat, 380051. Securities: : 5,00,000 equity shares of Rs. 10/- each in the following manner: • New Equity Shares on Reduction • 25,000 equity shares of Rs. 10/- each allotted pursuant to reduction of capital through approved Resolution Plan; • 425,000 equity shares of Rs. 10/- each • New Equity shares on preferential allotted to Successful Resolution Applicant and its Promoter Group and basis to SRA • 50,000 equity shares of Rs. 10/- allotted to Secured Financials Creditor on preferential • New Equity shares on preferential basis. basis to Secured Financial Creditor Distinctive numbers : 1- 500000 Scrip Code : 531171 Group : XT Market Lot : 1 Face Value & Paid up value : Rs. 10/- each fully paid up Scrip ID on BOLT System : DHARTI Abbreviated name on BOLT System : DHARTI ISIN No. : INE248C01021 Lock-in : Refer Annexure I 1. The brief particulars of the Resolution Plan are as mentioned below: The Resolution Plan under the provisions of the Insolvency and Bankruptcy Code, 2016, of the Company was approved as per the Hon’ble NCLT order dated Ahmedabad, vide order dated November 18, 2025. As per the NCLT approved Resolution Plan: - a. The entire shareholding held by the erstwhile promoters shall stand extinguished. b. Out of the existing paid-up equity share capital comprising 1,02,77,200 equity shares, 97,77,200 equity shares shall be cancelled/restructured, and the number of shares will be reduced to 5,00,000 equity shares of face value Rs. 10/- each. c. The entire shareholding of the Promoters and Promoter Group, whether as preference share capital or equity share capital shall be fully cancelled and stand reduced to zero. d. The shareholding of the existing public shareholders shall be restructured such that they hold 5% of the post- restructuring paid-up equity share capital. Accordingly, 25,000 equity shares of ₹10 each, out of the restructured capital of 5,00,000 equity shares, shall be allotted to the existing public shareholders on a proportionate basis based on their shareholding as on the date of approval of the Resolution Plan. e. 50,000 equity shares of Rs. 10/- each shall be allotted to the Secured Financial Creditors, over and above the upfront cash component payable to them in terms of the Resolution Plan. f. The balance 4,25,000 equity shares of Rs. 10/- each shall be allotted to the Successful Resolution Applicant (SRA) and its promoter group. Accordingly, the issued, subscribed and paid-up share capital of the Company has been changed from Rs. 10,27,72,000/- divided into 1,02,77,200 Equity Shares of the Face Value of Rs.10/- each to Rs. 50,00,000/- divided into 5,00,000 Equity Shares of the Face Value of Rs.10/- each. 2. As per Exchange Notice No. 20260218-9 dated February 18, 2026, the Company had fixed February 20, 2026, as record date for giving effect to the resolution plan. 3. All market participants of the Exchange may also note that currently equity shares allotted in dematerialized mode have been credited under the temporary ISIN in accordance with the SEBI circular no. CIR/MRD/DP/21/2012 dated August 02, 2012, regarding activation of ISIN in case of additional issue of shares/securities. Nitinkumar Pujari Nilima Burghate Assistant Vice President Deputy Manager